605177 东亚药业
午间休市 05-16 11:29:47
资讯
新帖
简况
东亚药业曲美布汀原料药获韩国注册证书
财中社 · 05-15 08:05
东亚药业曲美布汀原料药获韩国注册证书
东亚药业(605177.SH):曲美布汀原料药获得韩国原料药品注册证书
智通财经 · 05-15 07:33
东亚药业(605177.SH):曲美布汀原料药获得韩国原料药品注册证书
东亚药业05月15日获主力加仓4.1万元
市场透视 · 05-15 07:21
东亚药业05月15日获主力加仓4.1万元
东亚药业05月12日获主力加仓497.4万元
市场透视 · 05-12
东亚药业05月12日获主力加仓497.4万元
东亚药业截止04月18日股东人数1.12万户,人均持股1.01万股
市场透视 · 05-12
东亚药业截止04月18日股东人数1.12万户,人均持股1.01万股
化学制药行业盘中拉升,复旦复华涨5.49%
市场透视 · 05-09
化学制药行业盘中拉升,复旦复华涨5.49%
东亚药业(605177)2025年一季报简析:净利润减128.78%,三费占比上升明显
证券之星 · 04-30
东亚药业(605177)2025年一季报简析:净利润减128.78%,三费占比上升明显
东亚药业2024年财报:营收下滑11.66%,净利润亏损1.01亿元
金融界 · 04-30
东亚药业2024年财报:营收下滑11.66%,净利润亏损1.01亿元
东亚药业2024年报解读:净利润骤降183.02%,研发费用大增43.16%
新浪财经 · 04-29
东亚药业2024年报解读:净利润骤降183.02%,研发费用大增43.16%
东亚药业2024年亏损1.01亿元 营收降11.7%
财中社 · 04-29
东亚药业2024年亏损1.01亿元 营收降11.7%
图解东亚药业一季报:第一季度单季净利润同比减128.78%
证券之星 · 04-29
图解东亚药业一季报:第一季度单季净利润同比减128.78%
东亚药业(605177.SH)发布一季度业绩,归母净亏损691.96万元,由盈转亏
智通财经 · 04-29
东亚药业(605177.SH)发布一季度业绩,归母净亏损691.96万元,由盈转亏
东亚药业一季度净亏损691.96万元
格隆汇 · 04-29
东亚药业一季度净亏损691.96万元
东亚药业04月28日遭主力抛售281.0万元
市场透视 · 04-28
东亚药业04月28日遭主力抛售281.0万元
东亚药业04月25日遭主力抛售86万元
市场透视 · 04-25
东亚药业04月25日遭主力抛售86万元
东亚药业04月24日主力净流出76万元 散户资金买入
市场透视 · 04-24
东亚药业04月24日主力净流出76万元 散户资金买入
东亚药业:公司暂时没有应披露的回购、并购等计划
每日经济新闻 · 04-22
东亚药业:公司暂时没有应披露的回购、并购等计划
化学制药行业盘中拉升,威尔药业涨9.09%
市场透视 · 04-22
化学制药行业盘中拉升,威尔药业涨9.09%
东亚药业04月21日主力净流入47万元 散户资金抛售
市场透视 · 04-21
东亚药业04月21日主力净流入47万元 散户资金抛售
东亚药业04月18日主力净流出19万元 散户资金买入
市场透视 · 04-18
东亚药业04月18日主力净流出19万元 散户资金买入
加载更多
公司概况
公司名称:
浙江东亚药业股份有限公司
所属行业:
医药制造业
上市日期:
2020-11-25
主营业务:
浙江东亚药业股份有限公司的主营业务是化学原料药、医药中间体的研发、生产和销售。公司的主要产品是β-内酰胺类抗菌药、抗胆碱和合成解痉药、喹诺酮类抗菌药、皮肤用抗真菌药、粘痰溶解药、抗痛风药、降压药。公司先后获得“国家高新技术企业”“浙江省专利示范企业”“台州市管理创新十强企业”等称号。
发行价格:
31.13
{"stockData":{"symbol":"605177","market":"SH","secType":"STK","nameCN":"东亚药业","latestPrice":17.53,"timestamp":1747366187000,"preClose":17.42,"halted":0,"volume":696900,"delay":0,"changeRate":0.0063,"floatShares":112999999,"shares":114999999,"eps":-1.1472,"marketStatus":"午间休市","change":0.11,"latestTime":"05-16 11:29:47","open":17.47,"high":17.6,"low":17.32,"amount":12205200,"amplitude":0.0161,"askPrice":17.52,"askSize":17,"bidPrice":17.51,"bidSize":4,"shortable":0,"etf":0,"ttmEps":-1.1472,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1747371600000},"marketStatusCode":3,"adr":0,"adjPreClose":17.42,"symbolType":"stock","openAndCloseTimeList":[[1747359000000,1747366200000],[1747371600000,1747378800000]],"highLimit":19.16,"lowLimit":15.68,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":114739776,"isCdr":false,"pbRate":1.14,"roa":"--","roe":"--","epsLYR":-0.9,"committee":-0.280992,"marketValue":2011000000,"turnoverRate":0.0062,"status":0,"floatMarketCap":1974000000},"requestUrl":"/m/hq/s/605177","defaultTab":"news","newsList":[{"id":"2535894562","title":"东亚药业曲美布汀原料药获韩国注册证书","url":"https://stock-news.laohu8.com/highlight/detail?id=2535894562","media":"财中社","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2535894562?lang=zh_cn&edition=full","pubTime":"2025-05-15 16:05","pubTimestamp":1747296348,"startTime":"0","endTime":"0","summary":"5月15日,东亚药业(605177)发布公告,近日公司收到韩国食品药品监督管理局(韩国MFDS)颁发的曲美布汀原料药品注册证书。这一证书的获得标志着公司曲美布汀原料药在韩国市场的准入资格,预计将对公司拓展韩国医药市场产生积极影响,并促进其在其他海外市场的销售。曲美布汀具有促进胃动力不足或抑制胃动力过足的双重调节作用,能够治疗胃肠道运动功能紊乱引起的多种症状。相关数据显示,2024年度马来酸曲美布汀制剂的全国销售额约为3.72亿元。2025年一季度,东亚药业实现收入1.91亿元,归母净利润-692万元。文章来源:财中社原标题:东亚药业曲美布汀原料药获韩国注册证书","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250515161937a6e0119f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250515161937a6e0119f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","605177"],"gpt_icon":0},{"id":"2535989318","title":"东亚药业(605177.SH):曲美布汀原料药获得韩国原料药品注册证书","url":"https://stock-news.laohu8.com/highlight/detail?id=2535989318","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2535989318?lang=zh_cn&edition=full","pubTime":"2025-05-15 15:33","pubTimestamp":1747294382,"startTime":"0","endTime":"0","summary":"智通财经APP讯,东亚药业(605177.SH)发布公告,近日,公司收到韩国食品药品监督管理局(韩国MFDS)原料药品注册证书。曲美布汀具有促进胃动力不足或抑制胃动力过足的双重调节作用,可用于治疗胃肠道运动功能紊乱引起的食欲不振、恶心、呕吐、嗳气、腹胀、腹鸣、腹痛、腹泻便秘等症状。据相关数据显示,2024年度马来酸曲美布汀制剂全国销售额约为3.72亿元。公司曲美布汀原料药获得韩国原料药品注册证书,标志着公司曲美布汀原料药获得了在韩国的准入资格,将对公司拓展韩国的医药市场带来积极的影响,从而促进公司曲美布汀原料药在其他海外市场的销售。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1293505.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["605177","BK0239"],"gpt_icon":0},{"id":"2535816615","title":"东亚药业05月15日获主力加仓4.1万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2535816615","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2535816615?lang=zh_cn&edition=full","pubTime":"2025-05-15 15:21","pubTimestamp":1747293669,"startTime":"0","endTime":"0","summary":"05月15日, 东亚药业股价涨0.29%,报收17.42元,成交金额2617.6万元,换手率1.33%,振幅2.19%,量比0.94。东亚药业今日主力资金净流入4.1万元,上一交易日主力净流入228.3万元。|05月15日主力加仓幅度排名||#|股票简称|主力净额占比|#|王子新材|8.62%|#|通达股份|7.12%|#|川宁生物|6.48%|#|...|...|#1430|东亚药业|0.00%|东亚药业所在的化学制药行业,今日主力净流入12.76亿元,行业排名1/124。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250515171434a47f5a49&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250515171434a47f5a49&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","605177"],"gpt_icon":0},{"id":"2534024988","title":"东亚药业05月12日获主力加仓497.4万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2534024988","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2534024988?lang=zh_cn&edition=full","pubTime":"2025-05-12 15:21","pubTimestamp":1747034494,"startTime":"0","endTime":"0","summary":"05月12日, 东亚药业股价涨1.86%,报收17.52元,成交金额3703.0万元,换手率1.90%,振幅3.26%,量比1.07。东亚药业今日主力资金净流入497.4万元,上一交易日主力净流入254.7万元。|05月12日主力加仓幅度排名||#|股票简称|主力净额占比|#|宏工科技|9.67%|#|富岭股份|8.01%|#|中超控股|6.76%|#|...|...|#533|东亚药业|0.25%|东亚药业所在的化学制药行业,今日主力净流出6.05亿元,行业排名5/124。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250512173317a47b2a75&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250512173317a47b2a75&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["605177","BK0239"],"gpt_icon":0},{"id":"2534215308","title":"东亚药业截止04月18日股东人数1.12万户,人均持股1.01万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2534215308","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2534215308?lang=zh_cn&edition=full","pubTime":"2025-05-12 15:13","pubTimestamp":1747033990,"startTime":"0","endTime":"0","summary":"东亚药业披露公司股东人数最新情况,截止2025年04月18日,公司股东人数为1.12万户,较上期减少312户,环比减少2.68%。人均持仓股环比增长情形用户持仓来看,东亚药业人均持仓1.01万股,上期人均持仓9793股,环比增长3.13%,户均持股趋向集中。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250512151311a6dbd98c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250512151311a6dbd98c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","605177"],"gpt_icon":0},{"id":"2534914047","title":"化学制药行业盘中拉升,复旦复华涨5.49%","url":"https://stock-news.laohu8.com/highlight/detail?id=2534914047","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2534914047?lang=zh_cn&edition=full","pubTime":"2025-05-09 09:35","pubTimestamp":1746754541,"startTime":"0","endTime":"0","summary":"05月09日,化学制药行业盘中拉升,截至09点35分,化学制药行业整体指数上涨0.69%,报11095.540点。从个股上来看,该行业的成分股中,复旦复华涨5.49%,舒泰神涨幅超过5%。从资金上来看,截止发稿,化学制药行业主力净流入为1308.51万,其中复旦复华受到资金热捧,主力净流入1798.12万;拉长时间线来看,该板块近20日主力资金净流入-53.31亿。(以上内容为腾讯自选股基于公开消息,由程序或算法智能生成,仅作为用户看盘参考,不作为投资建议或交易依据。股市有风险,请谨慎决策。)","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250509093541a6d86536&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250509093541a6d86536&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["603669","600613","688166","600521","600624","BK0239","601089","600488","600420","BK0185","600267","600062","603168","603229","605507","603367","688189","BK0188","600276","BK0028","603707","605116","600513","BK0010","600079","600200","600812","688117","605177","600380","688578","BK0122","BK0175","BK0075","688566","600216","688506"],"gpt_icon":0},{"id":"2532018854","title":"东亚药业(605177)2025年一季报简析:净利润减128.78%,三费占比上升明显","url":"https://stock-news.laohu8.com/highlight/detail?id=2532018854","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2532018854?lang=zh_cn&edition=full","pubTime":"2025-05-01 06:35","pubTimestamp":1746052511,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理,近期东亚药业发布2025年一季报。截至本报告期末,公司营业总收入1.91亿元,同比下降45.85%,归母净利润-691.96万元,同比下降128.78%。本报告期东亚药业三费占比上升明显,财务费用、销售费用和管理费用总和占总营收同比增幅达97.55%。融资分红:公司上市5年以来,累计融资总额8.84亿元,累计分红总额1.33亿元,分红融资比为0.15。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025050100004613.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["605177"],"gpt_icon":0},{"id":"2531511850","title":"东亚药业2024年财报:营收下滑11.66%,净利润亏损1.01亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2531511850","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2531511850?lang=zh_cn&edition=full","pubTime":"2025-04-30 22:34","pubTimestamp":1746023694,"startTime":"0","endTime":"0","summary":"2025年4月30日,东亚药业发布了2024年年报。报告显示,公司全年实现营业收入11.98亿元,同比下降11.66%;归属于上市公司股东的净利润为-1.01亿元,同比大幅下降183.02%。研发投入创新高,但短期内拖累利润2024年,东亚药业在研发方面的投入达到1.39亿元,占营业收入的11.59%,创下历史新高。报告期内,公司营业收入同比下降11.66%,主要由于下游客户需求减少。","market":"sh","thumbnail":"http://imgcloud.jrjimg.cn/2025/04/cms_20250430223840532.jpg","type":0,"news_type":0,"thumbnails":["http://imgcloud.jrjimg.cn/2025/04/cms_20250430223840532.jpg"],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.jrj.com.cn/2025/04/30223450062195.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["605177"],"gpt_icon":0},{"id":"2531769901","title":"东亚药业2024年报解读:净利润骤降183.02%,研发费用大增43.16%","url":"https://stock-news.laohu8.com/highlight/detail?id=2531769901","media":"新浪财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2531769901?lang=zh_cn&edition=full","pubTime":"2025-04-30 00:43","pubTimestamp":1745945018,"startTime":"0","endTime":"0","summary":"从其公布的年报数据来看,多项关键指标出现了较大幅度的变动,其中净利润同比减少183.02%,研发费用同比增加43.16%,这些变化值得投资者密切关注。营业收入:市场需求波动致营收下滑2024年,东亚药业实现营业收入1,198,238,535.39元,与上一年的1,356,448,097.16元相比,减少了11.66%。从季度数据来看,第一季度至第四季度营业收入分别为352,582,674.10元、295,643,846.05元、314,792,722.32元、235,219,292.92元,呈现出波动下滑的趋势。公司解释称,主要原因包括营业收入减少、资产减值损失增加以及研发费用增加。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250430005621974a70c3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250430005621974a70c3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["605177"],"gpt_icon":0},{"id":"2531005735","title":"东亚药业2024年亏损1.01亿元 营收降11.7%","url":"https://stock-news.laohu8.com/highlight/detail?id=2531005735","media":"财中社","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2531005735?lang=zh_cn&edition=full","pubTime":"2025-04-29 20:20","pubTimestamp":1745929249,"startTime":"0","endTime":"0","summary":"报告期内,公司营业收入为11.98亿元,同比减少11.66%;归属于上市公司股东的净利润为-1.01亿元,同比减少183.02%。在管理层讨论与分析中,提到公司加大了对研发的投入,2024年度研发费用达到1.39亿元,占营业收入的11.59%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250429202117974a2412&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250429202117974a2412&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["605177"],"gpt_icon":0},{"id":"2531788104","title":"图解东亚药业一季报:第一季度单季净利润同比减128.78%","url":"https://stock-news.laohu8.com/highlight/detail?id=2531788104","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2531788104?lang=zh_cn&edition=full","pubTime":"2025-04-29 18:39","pubTimestamp":1745923167,"startTime":"0","endTime":"0","summary":"证券之星消息,东亚药业2025年一季报显示,公司主营收入1.91亿元,同比下降45.85%;归母净利润-691.96万元,同比下降128.78%;扣非净利润-1050.59万元,同比下降151.56%;负债率46.33%,投资收益73.75万元,财务费用13.01万元,毛利率35.37%。财报数据概要请见下图:以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025042900036614.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["605177"],"gpt_icon":0},{"id":"2531700852","title":"东亚药业(605177.SH)发布一季度业绩,归母净亏损691.96万元,由盈转亏","url":"https://stock-news.laohu8.com/highlight/detail?id=2531700852","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2531700852?lang=zh_cn&edition=full","pubTime":"2025-04-29 17:06","pubTimestamp":1745917587,"startTime":"0","endTime":"0","summary":"智通财经APP讯,东亚药业(605177.SH)发布2025年第一季度报告,公司第一季度营业收入1.91亿元,同比下降45.85%;归属于上市公司股东的净亏损691.96万元,由盈转亏;归属于上市公司股东的扣除非经常性损益的净亏损1050.59万元,由盈转亏;基本每股亏损0.06元/股。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1287372.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["605177","BK0239"],"gpt_icon":0},{"id":"2531271212","title":"东亚药业一季度净亏损691.96万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2531271212","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2531271212?lang=zh_cn&edition=full","pubTime":"2025-04-29 15:52","pubTimestamp":1745913134,"startTime":"0","endTime":"0","summary":"格隆汇4月29日丨东亚药业(605177.SH)发布一季报,2025年一季度实现营业总收入1.91亿元,同比下降45.85%;归属母公司股东净利润-691.96万元;基本每股收益为-0.06元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250429155214a6ccdee9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250429155214a6ccdee9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","605177"],"gpt_icon":0},{"id":"2530470906","title":"东亚药业04月28日遭主力抛售281.0万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2530470906","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2530470906?lang=zh_cn&edition=full","pubTime":"2025-04-28 19:26","pubTimestamp":1745839579,"startTime":"0","endTime":"0","summary":"04月28日, 东亚药业股价跌2.11%,报收16.23元,成交金额2723.1万元,换手率1.48%,振幅2.41%,量比1.04。东亚药业今日主力资金净流出281.0万元,连续3日净流出,上一交易日主力净流出86.0万元。该股近5个交易日下跌2.17%,主力资金累计净流出261.0万元,其中1个交易日为股价上涨时净流出;近20日主力资金累计净流入964.0万元,其中净流入天数为6日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250428194037a46a603c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250428194037a46a603c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["605177","BK0239"],"gpt_icon":0},{"id":"2530906899","title":"东亚药业04月25日遭主力抛售86万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2530906899","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2530906899?lang=zh_cn&edition=full","pubTime":"2025-04-25 15:23","pubTimestamp":1745565812,"startTime":"0","endTime":"0","summary":"04月25日, 东亚药业股价跌0.78%,报收16.58元,成交金额2303万元,换手率1.23%,振幅1.86%,量比0.87。东亚药业今日主力资金净流出86万元,上一交易日主力净流出76万元。该股近5个交易日上涨0.48%,主力资金累计净流入67万元;近20日主力资金累计净流入1148万元,其中净流入天数为6日。|04月25日主力加仓幅度排名||#|股票简称|主力净额占比|#|N众捷汽车|25.80%|#|天元智能|12.79%|#|九洲集团|10.34%|#|...|...|#3391|东亚药业|-0.05%|东亚药业所在的化学制药行业,今日主力净流出11.39亿元,行业排名1/124。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250425164800a4668c5c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250425164800a4668c5c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","605177"],"gpt_icon":0},{"id":"2529581627","title":"东亚药业04月24日主力净流出76万元 散户资金买入","url":"https://stock-news.laohu8.com/highlight/detail?id=2529581627","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2529581627?lang=zh_cn&edition=full","pubTime":"2025-04-24 15:21","pubTimestamp":1745479275,"startTime":"0","endTime":"0","summary":"04月24日, 东亚药业股价跌0.83%,报收16.71元,成交金额2312万元,换手率1.23%,振幅2.73%,量比0.87。东亚药业今日主力资金净流出76万元,上一交易日主力净流入209万元。该股近5个交易日上涨0.66%,主力资金累计净流入134万元;近20日主力资金累计净流出351万元,其中净流出天数为14日。|04月24日主力加仓幅度排名||#|股票简称|主力净额占比|#|N天有|22.97%|#|N江顺科技|15.83%|#|金凯生科|7.71%|#|...|...|#2676|东亚药业|-0.04%|东亚药业所在的化学制药行业,今日主力净流入2.98亿元,行业排名3/124。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250424161719a46506e4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250424161719a46506e4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","605177"],"gpt_icon":0},{"id":"2529367645","title":"东亚药业:公司暂时没有应披露的回购、并购等计划","url":"https://stock-news.laohu8.com/highlight/detail?id=2529367645","media":"每日经济新闻","labels":["buyback"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2529367645?lang=zh_cn&edition=full","pubTime":"2025-04-22 23:47","pubTimestamp":1745336870,"startTime":"0","endTime":"0","summary":"还有,现在监管机构鼓励上市公司兼并重组做大做强,东亚正在朝保健品和制剂领域发力,未来是否有收购意向以实现业务的快速拓展?公司暂时没有应披露的回购、并购等计划,后续如有相关计划,会严格按照法律法规要求履行信息披露义务,有关信息请以公司披露的公告为准。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025042223490094de54ed&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025042223490094de54ed&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"buyback","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","605177"],"gpt_icon":0},{"id":"2529588153","title":"化学制药行业盘中拉升,威尔药业涨9.09%","url":"https://stock-news.laohu8.com/highlight/detail?id=2529588153","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2529588153?lang=zh_cn&edition=full","pubTime":"2025-04-22 09:44","pubTimestamp":1745286262,"startTime":"0","endTime":"0","summary":"04月22日,化学制药行业盘中拉升,截至09点44分,化学制药行业整体指数上涨1.01%,报10985.070点。从个股上来看,该行业的成分股中,威尔药业涨9.09%,富祥药业、东诚药业等4只股涨幅超过5%。从资金上来看,截止发稿,化学制药行业主力净流入为-1.59亿,其中东诚药业受到资金热捧,主力净流入2513.18万;拉长时间线来看,该板块近20日主力资金净流入-68.34亿。(以上内容为腾讯自选股基于公开消息,由程序或算法智能生成,仅作为用户看盘参考,不作为投资建议或交易依据。股市有风险,请谨慎决策。)","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250422094422a6c316d4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250422094422a6c316d4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["603538","600267","600488","688356","600513","688166","688578","BK0275","688076","605177","BK0188","688247","600380","603676","603707","688117","600420","603229","688091","603811","BK0239","688513","605507","BK0028","688690","688799","688505","688189","600521","600789","688566","600216","603351","600276","688506","BK0060","600624","600613","600812","605116","600196"],"gpt_icon":0},{"id":"2529823424","title":"东亚药业04月21日主力净流入47万元 散户资金抛售","url":"https://stock-news.laohu8.com/highlight/detail?id=2529823424","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2529823424?lang=zh_cn&edition=full","pubTime":"2025-04-21 15:19","pubTimestamp":1745219990,"startTime":"0","endTime":"0","summary":"04月21日, 东亚药业股价涨0.55%,报收16.59元,成交金额2459万元,换手率1.32%,振幅2.30%,量比0.89。东亚药业今日主力资金净流入47万元,上一交易日主力净流出19万元。该股近5个交易日下跌0.36%,主力资金累计净流出421万元,其中1个交易日为股价上涨时净流出;近20日主力资金累计净流出546万元,其中净流出天数为13日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250421155455a460a83a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250421155455a460a83a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["605177","BK0239"],"gpt_icon":0},{"id":"2528535400","title":"东亚药业04月18日主力净流出19万元 散户资金买入","url":"https://stock-news.laohu8.com/highlight/detail?id=2528535400","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2528535400?lang=zh_cn&edition=full","pubTime":"2025-04-18 15:21","pubTimestamp":1744960903,"startTime":"0","endTime":"0","summary":"04月18日, 东亚药业股价跌0.60%,报收16.50元,成交金额2246万元,换手率1.21%,振幅3.01%,量比0.76。东亚药业今日主力资金净流出19万元,上一交易日主力净流入22万元。该股近5个交易日上涨1.29%,主力资金累计净流出547万元;近20日主力资金累计净流出547万元,其中净流出天数为13日。|04月18日主力加仓幅度排名||#|股票简称|主力净额占比|#|亚联机械|6.61%|#|永杰新材|6.36%|#|三夫户外|6.18%|#|...|...|#2631|东亚药业|-0.01%|东亚药业所在的化学制药行业,今日主力净流出7373万元,行业排名64/124。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250418163700a6bf1408&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250418163700a6bf1408&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","605177"],"gpt_icon":0}],"profile":{"ret":0,"serverTime":1747369112637,"stockEarnings":[{"period":"1week","weight":0.0069},{"period":"1month","weight":0.0381},{"period":"3month","weight":-0.0444},{"period":"6month","weight":-0.0634},{"period":"1year","weight":-0.3147},{"period":"ytd","weight":-0.1157}],"compareEarnings":[{"period":"1week","weight":0.0086},{"period":"1month","weight":0.0346},{"period":"3month","weight":0.0102},{"period":"6month","weight":0.015},{"period":"1year","weight":0.0836},{"period":"ytd","weight":0.0087}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"浙江东亚药业股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"11188人(较上一季度减少2.68%)","perCapita":"10062股","listingDate":"2020-11-25","address":"浙江省台州市三门县浦坝港镇沿海工业城","registeredCapital":"11473万元","survey":" 浙江东亚药业股份有限公司的主营业务是化学原料药、医药中间体的研发、生产和销售。公司的主要产品是β-内酰胺类抗菌药、抗胆碱和合成解痉药、喹诺酮类抗菌药、皮肤用抗真菌药、粘痰溶解药、抗痛风药、降压药。公司先后获得“国家高新技术企业”“浙江省专利示范企业”“台州市管理创新十强企业”等称号。","listedPrice":31.13},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.33.4","shortVersion":"4.33.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"东亚药业(605177)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供东亚药业(605177)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"东亚药业,605177,东亚药业股票,东亚药业股票老虎,东亚药业股票老虎国际,东亚药业行情,东亚药业股票行情,东亚药业股价,东亚药业股市,东亚药业股票价格,东亚药业股票交易,东亚药业股票购买,东亚药业股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"东亚药业(605177)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供东亚药业(605177)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}